Blog
Nayax (NYAX) Surpasses Q2 Earnings Estimates
Nayax (NYAX) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to a loss of $0.08 per share a year ago. These figures are
Creative Realities, Inc. (CREX) Beats Q2 Earnings and Revenue Estimates
Creative Realities, Inc. (CREX) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to a loss of $0.06 per share a
Targa Resources Q2 Earnings Beat Estimates, Revenues Miss
Targa Resources Corp. TRGP reported second-quarter 2025 earnings of $2.87 per share, which beat the Zacks Consensus Estimate of $1.91. The bottom line also improved from the year-ago quarter’s level
Will Chevron's Permian Production Strength Power Future Gains?
Chevron Corporation CVX is sharpening its focus on the Permian Basin, where it continues to expand output through efficiency gains and disciplined development. The company is leveraging digital
Sea Limited Q2 Earnings Miss Estimates, Revenues Rise Y/Y
Sea Limited SE reported adjusted earnings of 85 cents per share in the second quarter of 2025, missing the Zacks Consensus Estimate by 14.14%. The company posted earnings of 46 cents per share in
MDT Stock Trades Cheaper Than Peers Ahead of Q1 Earnings: Time to Buy?
Medtronic plc MDT is scheduled to report first-quarter fiscal 2026 results on Aug. 19, before the opening bell.
In the last reported quarter, the company’s adjusted earnings of $1.62 exceeded the
TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move?
Recently, Tempus AI TEM updated its sales guidance for 2025. It did so for the second time within six months, backed by a strong second-quarter performance. Full-year revenues are now expected to be
Will Breyanzi's Strong Uptake Help BMY Offset Generic Competition?
Bristol Myers’ (BMY) CAR T cell therapy Breyanzi (lisocabtagene maraleucel; liso-cel) posted strong growth in the second quarter.
Breyanzi is a CD19-directed CAR T cell therapy with a 4-1BB
Gauzy Ltd. (GAUZ) Reports Q2 Loss, Lags Revenue Estimates
Gauzy Ltd. (GAUZ) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.88 per share a year ago. These figures are
Zacks Industry Outlook Highlights Globant and NetEase
Is the Options Market Predicting a Spike in Canadian Pacific Stock?
Investors in Canadian Pacific Kansas City Limited CP need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 19, 2025 $50 Call had some of the
Zacks Industry Outlook Highlights Broadcom and Applied Materials
If You Invested $1000 in Aecom Technology a Decade Ago, This is How Much It'd Be Worth Now
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and
Here's How Much a $1000 Investment in BlackRock Made 10 Years Ago Would Be Worth Today
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and
If You Invested $1000 in Tractor Supply a Decade Ago, This is How Much It'd Be Worth Now
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and
Alithya Group (ALYAF) Beats Q1 Earnings Estimates
Alithya Group (ALYAF) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.04 per share a year ago. These
Sapiens (SPNS) Surpasses Q2 Earnings and Revenue Estimates
Sapiens (SPNS) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.37 per share a year ago. These figures
Lowe's Q2 2025 Earnings Preview: Is LOW Ready to Surprise the Street?
As Lowe's Companies, Inc. LOW prepares to unveil its second-quarter fiscal 2025 earnings on Aug. 20, before the opening bell, investors are eager to see if the company can beat market expectations
Implied Volatility Surging for Baldwin Insurance Stock Options
Investors in The Baldwin Insurance Group, Inc. BWIN need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 19, 2025 $20 Call had some of the
Sanara MedTech Inc. (SMTI) Reports Q2 Loss, Tops Revenue Estimates
Sanara MedTech Inc. (SMTI) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to a loss of $0.41 per share a year ago. These
Local Bounti Corporation (LOCL) Reports Q2 Loss, Misses Revenue Estimates
Local Bounti Corporation (LOCL) came out with a quarterly loss of $1.63 per share versus the Zacks Consensus Estimate of a loss of $1.95. This compares to a loss of $3 per share a year ago. These
Arcos Dorados (ARCO) Tops Q2 Earnings and Revenue Estimates
Arcos Dorados (ARCO) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.13 per share a year ago. These
Hologic Eyes Organic Growth Rebound in 2026 on Breast Health Strength
Hologic HOLX completed its annual strategic planning process earlier this year and expects to get back to solid mid-single-digit organic revenue growth next year and beyond. A major driver of this



